Summary:
The primary objective of the study is to evaluate the efficacy of troriluzole as adjunctive therapy compared to placebo in subjects with OCD who have had an inadequate response to their current OCD treatment based on the change in their Y-BOCS score.
Qualified Participants Must:
• Male and female outpatient subjects between the ages of 18 - 65 years
•
Patients may have failed SOC in the past but must also be having an inadequate response to their current Standard Of Care